144 related articles for article (PubMed ID: 32002359)
21. A Comparative Cytotoxic Evaluation of Disulfiram Encapsulated PLGA Nanoparticles on MCF-7 Cells.
Fasehee H; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH; Faghihi S
Int J Hematol Oncol Stem Cell Res; 2017 Apr; 11(2):102-107. PubMed ID: 28875004
[No Abstract] [Full Text] [Related]
22. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
23. Polyhydroxyalkanoate Decelerates the Release of Paclitaxel from Poly(lactic-co-glycolic acid) Nanoparticles.
Lee SY; Kim SY; Ku SH; Park EJ; Jang DJ; Kim ST; Kim SB
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015244
[TBL] [Abstract][Full Text] [Related]
24. Quercetin against MCF7 and CAL51 breast cancer cell lines: apoptosis, gene expression and cytotoxicity of nano-quercetin.
Mohammed HA; Sulaiman GM; Anwar SS; Tawfeeq AT; Khan RA; Mohammed SAA; Al-Omar MS; Alsharidah M; Rugaie OA; Al-Amiery AA
Nanomedicine (Lond); 2021 Sep; 16(22):1937-1961. PubMed ID: 34431317
[TBL] [Abstract][Full Text] [Related]
25. Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization.
Lomis N; Westfall S; Farahdel L; Malhotra M; Shum-Tim D; Prakash S
Nanomaterials (Basel); 2016 Jun; 6(6):. PubMed ID: 28335244
[TBL] [Abstract][Full Text] [Related]
26. A new core-shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma.
Xie MH; Fu ZL; Hua AL; Zhou JF; Chen Q; Li JB; Yao S; Cai XJ; Ge M; Zhou L; Wu J
Front Oncol; 2022; 12():932156. PubMed ID: 36185205
[TBL] [Abstract][Full Text] [Related]
27. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
28. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
López-Gasco P; Iglesias I; Benedí J; Lozano R; Teijón JM; Blanco MD
J Microencapsul; 2011; 28(5):417-29. PubMed ID: 21736526
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles.
Zou L; Chen F; Bao J; Wang S; Wang L; Chen M; He C; Wang Y
Drug Deliv; 2016; 23(3):908-16. PubMed ID: 24904975
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
32. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
34. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
[TBL] [Abstract][Full Text] [Related]
35. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
[TBL] [Abstract][Full Text] [Related]
36. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
Hu L; Li M; Zhang Z; Shen Y; Guo S
Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274
[TBL] [Abstract][Full Text] [Related]
37. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
38. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
39. Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
Shen JM; Yin T; Tian XZ; Gao FY; Xu S
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7014-24. PubMed ID: 23815399
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
